Succipro
We are a spin-off company from Pere Virgili Health Research institute (IISPV) and Rovira Virgili University. We are expert in succinate and are developing first-in-class molecules able to modulate succinate, a metabolite with pro-inflammatory properties that is increased in many metabolic and inflammatory disorders. The company has a diversified pipeline of candidates at an early preclinical phase and is working with several clinical indicacions, which include Type 2 Diabetes, obesity, Inflammatory bowel Disease and Non-Alcoholic Steatohepatitis
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Succipro
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Succipro
3 distinct titles indexed · top 3 shown.
- 1& ()
- 1co-founder and scientific ceo
- 1postdoctoral scientist
Sign up to unlock all 4 contacts at Succipro
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Succipro
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.